Sino Biopharmaceutical (1177.HK) - EPS (earnings per share)

EPS in 2021 (TTM): S$0.04839

According to Sino Biopharmaceutical's latest financial reports the company's current EPS (TTM) is S$0.04632. In 2023 the company made an earnings per share (EPS) of S$0.02309 a decrease over its 2022 EPS that were of S$0.02557.

EPS history for Sino Biopharmaceutical from 1999 to 2021

Annual EPS

Year	EPS	Change
2023	S$0.02309	-9.68%
2022	S$0.02557	-83.86%
2021	S$0.16	440.46%
2020	S$0.02930	7.54%
2019	S$0.02725	-70.37%
2018	S$0.09195	254.37%
2017	S$0.02595	41.55%
2016	S$0.01833	2.59%
2015	S$0.01787	17.63%
2014	S$0.01519	45.97%
2013	S$0.01041	16.34%
2012	S$0.008945	93.4%
2011	S$0.004625	-20.02%
2010	S$0.005783	33.16%
2009	S$0.004343	774.72%
2008	S$0.0004965	-79.69%
2007	S$0.002445	58.8%
2006	S$0.001540	-91.05%
2005	S$0.01720	723.97%
2004	S$0.002087	105.48%
2003	S$0.001016	-67.27%
2002	S$0.003103	-8.26%
2001	S$0.003382	17.18%
2000	S$0.002887	1.03%
1999	S$0.002857

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

EPS for Sino Biopharmaceutical (1177.HK)